CN110339304A - A kind of antidepression composite essential oil containing CBD ingredient - Google Patents

A kind of antidepression composite essential oil containing CBD ingredient Download PDF

Info

Publication number
CN110339304A
CN110339304A CN201910786404.0A CN201910786404A CN110339304A CN 110339304 A CN110339304 A CN 110339304A CN 201910786404 A CN201910786404 A CN 201910786404A CN 110339304 A CN110339304 A CN 110339304A
Authority
CN
China
Prior art keywords
oil
ingredient
essential
essential oil
antidepression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910786404.0A
Other languages
Chinese (zh)
Inventor
项伟
顾文云
李铖
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yunnan Han Musen Biotechnology LLC
Original Assignee
Yunnan Han Musen Biotechnology LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yunnan Han Musen Biotechnology LLC filed Critical Yunnan Han Musen Biotechnology LLC
Priority to CN201910786404.0A priority Critical patent/CN110339304A/en
Publication of CN110339304A publication Critical patent/CN110339304A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/238—Saposhnikovia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
    • A61K36/268—Asarum (wild ginger)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/285—Aucklandia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/44—Ebenaceae (Ebony family), e.g. persimmon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488—Pueraria (kudzu)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/489—Sophora, e.g. necklacepod or mamani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/52—Juglandaceae (Walnut family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/69—Polygalaceae (Milkwort family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/714—Aconitum (monkshood)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734—Crataegus (hawthorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/738—Rosa (rose)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/79—Schisandraceae (Schisandra family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/84—Valerianaceae (Valerian family), e.g. valerian
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/89—Cyperaceae (Sedge family)
    • A61K36/8905—Cyperus (flatsedge)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/894—Dioscoreaceae (Yam family)
    • A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/898—Orchidaceae (Orchid family)
    • A61K36/8988—Gastrodia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a kind of antidepression essential oil containing CBD ingredient, which includes 0.1~3% ingredient of CBD by weight percentage.Beneficial effects of the present invention are, product of the invention is open Land use systems on the basis of existing cannabidiol essential oil, increase commodity diversity, accomplish fluently solid technical foundation to integrate with international product.Product of the invention has antidepressant basic curative effect, it and further include other medical efficacies, it is to be noted that other Chinese medicines joined together meet the combination principle of Chinese medicine according to the essential oil that routine techniques is prepared, it is functionally even more the effect for realizing one-plus-one and being greater than two.Antidepression effect of the present invention is very significant, and combines effect after other essential oil of traditional Chinese medicine more preferable, and What is more, and the mode antidepressant effect in conjunction with smearing is more significant.Method and product of the invention highly at home, international promote.

Description

A kind of antidepression composite essential oil containing CBD ingredient
Technical field
The invention belongs to derived essential oil technical fields；Particularly belong to a kind of composite essential oil ingredient skill containing CBD ingredient Art field, and the composite essential oil have effects that it is antidepressant.
Background technique
Cannabidiol (Cannabidiol, abbreviation CBD) is the main chemical compositions in medicinal plant hemp, extracts from female Property hemp plant, be the non-habituation ingredient in hemp, have anti-spasm, antianxiety, anti-inflammatory pharmacological action, can not only act on In the treatment of a variety of difficult diseases, the hallucinogenic action that tetrahydrocannabinol (THC) generates human body can also be effectively eliminated, is claimed For " anti-drug compound ".
By in August, 2019, about cannabidiol, the utility model patent authorized has 8, is respectively: 1, for big The Preparation equipment of numb diphenol；2, for the extraction equipment in the preparation process of cannabidiol；3, a kind of industrial hemp extracts hemp The environmentally friendly extraction element of diphenol；4, the production equipment of high-purity cannabidiol；5, a kind of industrial hemp extracts point of cannabidiol From purification devices；6, a kind of for extracting the chromatographic apparatus of cannabidiol in industrial hemp；7, a kind of to be extracted from industrial hemp The integrated system of cannabidiol；8, the industrial hemp extraction of essential oil equipment rich in cannabidiol.The patent of invention authorized has 5 ?；1, new cannabidiol quinone derivative；2, numb medicinal extract of a kind of fire rich in cannabidiol and preparation method thereof；3, one kind is rich in The industrial hemp method of extraction of essential oil and its extract equipment of cannabidiol；4, the numb concentrated protein powder of a kind of fire rich in cannabidiol And preparation method thereof；5, purposes of the plant cannabinoids cannabidivarin (CBDV) in treatment epilepsy.In the patent of authorization, only There is the purposes function of being related to cannabidiol.This development like a raging fire with international, domestic cannabidiol market is pole not phase Claim.
The research institution most authoritative as Chinese crudefiber crop research: Hemp Inst., China Academy of Agricultural Sciences, in 2018, Three patents about cannabidiol have been declared within 2019 respectively: 1) a kind of preparation method of cannabidiol, hemp obtained two Phenol and application thereof；2) a kind of method for separating cannabidiol；3) cannabidiol, cannabidiolic acid, it is a kind of in tetrahydrocannabinol or The method for qualitative and quantitative detection of several substances；Technology contents involved in this three patent application manuscripts are the system of cannabidiol It is standby, separation and detection method, although first has been related to purposes, be only in short " cannabidiol preparation cancer, Application in epilepsy, schizophrenia and antidepressant agents "；How there is no prepare anticancer drug to full text；How treatment is prepared Epilepsy, schizophrenia, depression drug describe in detail.Cannabidiol can be found natively from chemical products catalogue Disclose 12 functions: 1) anti-spasm acts on；2) antianxiety, sedation；3) anti-insomnia acts on；4) emesis acts on；5) Anti-inflammatory effect；6) anti-epileptic；7) antitumor action；8) neuroprotection；9) metabolism and immunoregulation effect；10) heart is protected Blood vessel function；11) liver protection effect；12) antibacterial action.But in the prior art to ten branch office of implementation method/mode of these effects The open form as capsule, plaster, health liquor, cosmetics, habit-breaking candy for smokers of limit, only part exists；It is relevant to essential oil Only one: a kind of industrial hemp method of extraction of essential oil and its extract equipment rich in cannabidiol, this is also only by hemp two The method and its equipment that the essential oil of phenol is extract；How the cannabidiol essential oil extracting not to be used alone or such as What is recorded with the method that other essential oils are applied in combination, and the exactly clear above-mentioned technological deficiency of the present invention puts forth effort to research and develop related compound essence Oil product has overcome the blank of correlative technology field.
Summary of the invention
The present invention is precisely in order to the defect that solves the above problems, provides a kind of antidepression essential oil containing CBD ingredient.
The present invention adopts the following technical scheme that realization.
A kind of antidepression essential oil containing CBD ingredient, the essential oil include CBD0.1 by weight percentage~3% one-tenth Point.
It is further that the present invention essential oil includes plants essential oil A ingredient, plants essential oil A ingredient are as follows: with weight percent Juniper berry oil 10~50%, persimmon oil 10~50%, the crab oil 10~40% of meter.
It is further that the present invention essential oil includes plants essential oil B component, the plants essential oil B component are as follows: with weight percent The peony oil 0~30% of meter, jasmine oil 0~30%, Chinese rose caul-fat 0~30%, green mandarin oil 0~30%, senega root oil 0~20%, Narcissus oil 0~20%, day sesame oil 0~10%, Rhizoma Atractylodis Macrocephalae oil 0~20%, oil of Radix Sapshnikoviae 0~20%, doubleteeth pubescent angelica oil 0~20%, oil of Herba Asari Forbesii 0 ~10%, inulol 0~20%, walnut oil 0~30%, spikenard oil 0~20%, curcuma oil 0~20%, nutgrass galingale oil 0~20%, Monkshood oil 0~20%, dodder oil 0~30%, magnolia vine fruit oil 0~20%, Pueraria lobota oil 0~20%, radix ampelopsis oil 0~20%, mountain beans Root oil 0~10%, xanthate seed oil 0~20%, caulis sinomenii oil 0~20%, Rhizoma Acori Graminei oil 0~20%, kiss-me oil 0~20%, Sword bean oil 0~20%.
It is further that persimmon oil is using persimmon fruit and calyx and receptacle of a persimmon common combination, so in plants essential oil A ingredient of the present invention The persimmon oil product produced afterwards using general essential oil production technology.
It is further that crab oil is to use common group of haw berry and May bloom in plants essential oil A ingredient of the present invention It closes, the hawthorn oil product then produced using general essential oil production technology.
It is further that the present invention essential oil consists of the following components in percentage by weight: the ingredient of CBD1~2%, juniperko Oil 15~25%, persimmon oil 15~25%, crab oil 10~20%, green mandarin oil 5~15%, senega root oil 5~10%, spikenard oil 5 ~10%, dodder oil 10~25%, Pueraria lobota oil 5~15%, Rhizoma Acori Graminei oil 10~15%.
It is further that the present invention essential oil consists of the following components in percentage by weight: the ingredient of CBD1~2.5%, needle juniper Seed oil 20~30%, persimmon oil 10~20%, crab oil 10~20%, peony oil 10~20%, day sesame oil 5~8%, Rhizoma Atractylodis Macrocephalae oil 10~15%, oil of Radix Sapshnikoviae 10~12%, spikenard oil 5~10%, caulis sinomenii oil 5~10%.
It is further that the present invention essential oil consists of the following components in percentage by weight: the ingredient of CBD1~3%, juniperko Oily 10~20%, persimmon oil 20~30%, crab oil 10~20%, Chinese rose caul-fat 10~20%, doubleteeth pubescent angelica oil 10~15%, wild ginger Oily 5~8%, inulol 10~12%, radix ampelopsis oil 5~10%, sword bean oil 5~15%.
It is further that the present invention essential oil consists of the following components in percentage by weight: the ingredient of CBD0.1~1%, needle juniper Seed oil 10~20%, persimmon oil 10~20%, crab oil 10~20%, jasmine oil 10~20%, narcissus oil 10~15%, walnut Oily 5~8%, curcuma oil 12~20%, nutgrass galingale oil 10~12%, radix ampelopsis oil 5~10%.
It is further that the present invention essential oil consists of the following components in percentage by weight: the ingredient of CBD1~2%, juniperko Oil 25~35%, persimmon oil 10~15%, crab oil 10~25%, green mandarin oil 10~20%, monkshood oil 8~12%, Schisandra chinensis Oily 5~12%, subprostrate sophora oil 5~8%, xanthate seed oil 6~12%, kiss-me oil 5~12%.
Beneficial effects of the present invention are, product of the invention is open on the basis of existing cannabidiol essential oil utilizes Mode increases commodity diversity, accomplishes fluently solid technical foundation to integrate with international product.Product of the invention has anti-suppression Strongly fragrant basic curative effect, and further include other medical efficacies, it is pointed out that other Chinese medicines joined together are according to routine techniques The essential oil being prepared meets the combination principle of Chinese medicine, is functionally even more the effect for realizing one-plus-one and being greater than two.The present invention Antidepression effect is very significant, and combines effect after other essential oil of traditional Chinese medicine more preferable, and What is more, in conjunction with the mode antidepression of smearing It acts on more significant.Method and product of the invention highly at home, international promote.
The present invention is further explained With reference to embodiment.
Specific embodiment
A kind of antidepression essential oil containing CBD ingredient, the essential oil include CBD0.1 by weight percentage~3% one-tenth Point.
It is further that the present invention essential oil includes plants essential oil A ingredient, plants essential oil A ingredient are as follows: with weight percent Juniper berry oil 10~50%, persimmon oil 10~50%, the crab oil 10~40% of meter.
It is further that the present invention essential oil includes plants essential oil B component, the plants essential oil B component are as follows: with weight percent The peony oil 0~30% of meter, jasmine oil 0~30%, Chinese rose caul-fat 0~30%, green mandarin oil 0~30%, senega root oil 0~20%, Narcissus oil 0~20%, day sesame oil 0~10%, Rhizoma Atractylodis Macrocephalae oil 0~20%, oil of Radix Sapshnikoviae 0~20%, doubleteeth pubescent angelica oil 0~20%, oil of Herba Asari Forbesii 0 ~10%, inulol 0~20%, walnut oil 0~30%, spikenard oil 0~20%, curcuma oil 0~20%, nutgrass galingale oil 0~20%, Monkshood oil 0~20%, dodder oil 0~30%, magnolia vine fruit oil 0~20%, Pueraria lobota oil 0~20%, radix ampelopsis oil 0~20%, mountain beans Root oil 0~10%, xanthate seed oil 0~20%, caulis sinomenii oil 0~20%, Rhizoma Acori Graminei oil 0~20%, kiss-me oil 0~20%, Sword bean oil 0~20%.
It is further that persimmon oil is using persimmon fruit and calyx and receptacle of a persimmon common combination, so in plants essential oil A ingredient of the present invention The persimmon oil product produced afterwards using general essential oil production technology.
It is further that crab oil is to use common group of haw berry and May bloom in plants essential oil A ingredient of the present invention It closes, the hawthorn oil product then produced using general essential oil production technology.
It is further that the present invention essential oil consists of the following components in percentage by weight: the ingredient of CBD1~2%, juniperko Oil 15~25%, persimmon oil 15~25%, crab oil 10~20%, green mandarin oil 5~15%, senega root oil 5~10%, spikenard oil 5 ~10%, dodder oil 10~25%, Pueraria lobota oil 5~15%, Rhizoma Acori Graminei oil 10~15%.
It is further that the present invention essential oil consists of the following components in percentage by weight: the ingredient of CBD1~2.5%, needle juniper Seed oil 20~30%, persimmon oil 10~20%, crab oil 10~20%, peony oil 10~20%, day sesame oil 5~8%, Rhizoma Atractylodis Macrocephalae oil 10~15%, oil of Radix Sapshnikoviae 10~12%, spikenard oil 5~10%, caulis sinomenii oil 5~10%.
It is further that the present invention essential oil consists of the following components in percentage by weight: the ingredient of CBD1~3%, juniperko Oily 10~20%, persimmon oil 20~30%, crab oil 10~20%, Chinese rose caul-fat 10~20%, doubleteeth pubescent angelica oil 10~15%, wild ginger Oily 5~8%, inulol 10~12%, radix ampelopsis oil 5~10%, sword bean oil 5~15%.
It is further that the present invention essential oil consists of the following components in percentage by weight: the ingredient of CBD0.1~1%, needle juniper Seed oil 10~20%, persimmon oil 10~20%, crab oil 10~20%, jasmine oil 10~20%, narcissus oil 10~15%, walnut Oily 5~8%, curcuma oil 12~20%, nutgrass galingale oil 10~12%, radix ampelopsis oil 5~10%.
It is further that the present invention essential oil consists of the following components in percentage by weight: the ingredient of CBD1~2%, juniperko Oil 25~35%, persimmon oil 10~15%, crab oil 10~25%, green mandarin oil 10~20%, monkshood oil 8~12%, Schisandra chinensis Oily 5~12%, subprostrate sophora oil 5~8%, xanthate seed oil 6~12%, kiss-me oil 5~12%.
Essential oil product of the invention is divided to two kinds, a kind of for conventional liquid condition, can by directly according to essential oil in a manner of it is straight Connect use (when stablizing preservation, be stored in 2-8 DEG C of environment, and be nontransparent container)；Another kind is using adsorbent and bonding Agent, the adsorbent are the mixture of the diatomite that mass ratio is 1:1 and sawdust；Adhesive is pregelatinized starch；With absorption One extract of agent adsorption method is added adhesive and mixes, is pressed into champignon tablet by tablet press machine.
It should be noted that liquid condition essential oil is when in use, it not only include the user that the conventional descendant of volatilization naturally smells Formula further includes the mode that the composite essential oil product after certain combinations is directly smeared, composite essential oil product is gently such as massaged smearing Behind ear, at chin, behind temple, neck, below forehead and nose or wipe in sole.
It is above-described be only some embodiments of the invention (since formula of the invention belongs to numberical range, therefore Embodiment cannot exhaustion, protection scope documented by the present invention wants the point range to be with numberical range and other technologies of the invention It is quasi-), well known particular content or common sense do not describe excessively herein in scheme.It should be pointed out that above-described embodiment is not with any side The formula limitation present invention, it is for those skilled in the art, all to be obtained by the way of equivalent substitution or equivalent transformation Technical solution is fallen within the scope of protection of the present invention.This application claims protection scope should be with the content of its claim Standard, the records such as specific embodiment in specification can be used for explaining the content of claim.

Claims (10)

1. a kind of antidepression essential oil containing CBD ingredient, which is characterized in that the essential oil includes CBD by weight percentage 0.1~3% ingredient.
2. the antidepression essential oil according to claim 1 containing CBD ingredient, which is characterized in that the essential oil includes plant essence Oily A ingredient, plants essential oil A ingredient are as follows: juniper berry oil 10~50%, persimmon oil 10~50%, mountain by weight percentage Short, bristly hair or beard oil 10~40%.
3. the antidepression essential oil according to claim 2 containing CBD ingredient, which is characterized in that the essential oil includes plant essence Oily B component, the plants essential oil B component are as follows: peony oil 0~30% by weight percentage, jasmine oil 0~30%, China rose Oil 0~30%, green mandarin oil 0~30%, senega root oil 0~20%, narcissus oil 0~20%, day sesame oil 0~10%, Rhizoma Atractylodis Macrocephalae oil 0~ 20%, oil of Radix Sapshnikoviae 0~20%, doubleteeth pubescent angelica oil 0~20%, oil of Herba Asari Forbesii 0~10%, inulol 0~20%, walnut oil 0~30%, sweet Pine tar 0~20%, curcuma oil 0~20%, nutgrass galingale oil 0~20%, monkshood oil 0~20%, dodder oil 0~30%, Schisandra chinensis Oily 0~20%, Pueraria lobota oil 0~20%, radix ampelopsis oil 0~20%, subprostrate sophora oil 0~10%, xanthate seed oil 0~20%, caulis sinomenii oil 0 ~20%, Rhizoma Acori Graminei oil 0~20%, kiss-me oil 0~20%, sword bean oil 0~20%.
4. the antidepression essential oil according to claim 1 containing CBD ingredient, which is characterized in that the plants essential oil A at Persimmon oil is then to be produced using the persimmon oil that general essential oil production technology is produced using persimmon fruit and calyx and receptacle of a persimmon common combination in point Product.
5. the antidepression essential oil according to claim 1 containing CBD ingredient, which is characterized in that the plants essential oil A at Crab oil is the hawthorn then produced using general essential oil production technology using haw berry and May bloom common combination in point Oil product.
6. the antidepression essential oil according to claim 3 containing CBD ingredient, which is characterized in that the essential oil is by following weight The group of percentage is grouped as: 1~2% ingredient of CBD, juniper berry oil 15~25%, persimmon oil 15~25%, crab oil 10~ 20%, green mandarin oil 5~15%, senega root oil 5~10%, spikenard oil 5~10%, dodder oil 10~25%, Pueraria lobota oil 5~15%, Rhizoma Acori Graminei oil 10~15%.
7. the antidepression essential oil according to claim 3 containing CBD ingredient, which is characterized in that the essential oil is by following weight The group of percentage is grouped as: 1~2.5% ingredient of CBD, juniper berry oil 20~30%, persimmon oil 10~20%, crab oil 10~ 20%, peony oil 10~20%, day sesame oil 5~8%, Rhizoma Atractylodis Macrocephalae oil 10~15%, oil of Radix Sapshnikoviae 10~12%, spikenard oil 5~10%, Caulis sinomenii oil 5~10%.
8. the antidepression essential oil according to claim 3 containing CBD ingredient, which is characterized in that the essential oil is by following weight The group of percentage is grouped as: 1~3% ingredient of CBD, juniper berry oil 10~20%, persimmon oil 20~30%, crab oil 10~ 20%, Chinese rose caul-fat 10~20%, doubleteeth pubescent angelica oil 10~15%, oil of Herba Asari Forbesii 5~8%, inulol 10~12%, radix ampelopsis oil 5~ 10%, sword bean oil 5~15%.
9. the antidepression essential oil according to claim 3 containing CBD ingredient, which is characterized in that the essential oil is by following weight The group of percentage is grouped as: 0.1~1% ingredient of CBD, juniper berry oil 10~20%, persimmon oil 10~20%, crab oil 10~ 20%, jasmine oil 10~20%, narcissus oil 10~15%, walnut oil 5~8%, curcuma oil 12~20%, nutgrass galingale oil 10~ 12%, radix ampelopsis oil 5~10%.
10. the antidepression essential oil according to claim 3 containing CBD ingredient, which is characterized in that the essential oil is by following weight The group of percentage is grouped as: 1~2% ingredient of CBD, juniper berry oil 25~35%, persimmon oil 10~15%, crab oil 10~ 25%, green mandarin oil 10~20%, monkshood oil 8~12%, magnolia vine fruit oil 5~12%, subprostrate sophora oil 5~8%, xanthate seed oil 6~ 12%, kiss-me oil 5~12%.
CN201910786404.0A 2019-08-23 2019-08-23 A kind of antidepression composite essential oil containing CBD ingredient Pending CN110339304A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910786404.0A CN110339304A (en) 2019-08-23 2019-08-23 A kind of antidepression composite essential oil containing CBD ingredient

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910786404.0A CN110339304A (en) 2019-08-23 2019-08-23 A kind of antidepression composite essential oil containing CBD ingredient

Publications (1)

Publication Number Publication Date
CN110339304A true CN110339304A (en) 2019-10-18

Family

ID=68181172

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910786404.0A Pending CN110339304A (en) 2019-08-23 2019-08-23 A kind of antidepression composite essential oil containing CBD ingredient

Country Status (1)

Country Link
CN (1) CN110339304A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112472661A (en) * 2020-12-11 2021-03-12 云南苏旺润生物医药有限公司 Cannabidiol massage oil composition and preparation method and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107951869A (en) * 2016-10-14 2018-04-24 汉义生物科技（北京）有限公司 Pharmaceutical preparation and its application containing cannabidiol
CN109627148A (en) * 2018-11-28 2019-04-16 中国农业科学院麻类研究所 A kind of preparation method of cannabidiol, cannabidiol obtained and application thereof
CN109999122A (en) * 2019-04-25 2019-07-12 武汉圣润生物科技有限公司 A kind of cannabidiol health liquor and preparation method thereof improving depression

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107951869A (en) * 2016-10-14 2018-04-24 汉义生物科技（北京）有限公司 Pharmaceutical preparation and its application containing cannabidiol
CN109627148A (en) * 2018-11-28 2019-04-16 中国农业科学院麻类研究所 A kind of preparation method of cannabidiol, cannabidiol obtained and application thereof
CN109999122A (en) * 2019-04-25 2019-07-12 武汉圣润生物科技有限公司 A kind of cannabidiol health liquor and preparation method thereof improving depression

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
（英）阿吉•艾瑞著；卢树强译: "《5种神奇的自然保健疗法》", 31 March 2010, 黑龙江科学技术出版社 *
MYADMIN: "大麻二酚（CBD）的好处和用途及其副作用", 《HTTP://WWW.BJGDZ.COM/2019/0110/3138.HTML，大麻二酚（CBD）的好处和用途及其副作用》 *
周幸来: "《神经精神疾病临证药对》", 31 January 2014, 人民军医出版社 *
杜恩伟、王克: "《抑郁症的自我疗法》", 31 December 2006, 杜恩伟、王克 *
黄世敬等: "《抗抑郁中药良方》", 29 February 2016, 金盾出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112472661A (en) * 2020-12-11 2021-03-12 云南苏旺润生物医药有限公司 Cannabidiol massage oil composition and preparation method and application thereof

Similar Documents

Publication Publication Date Title
Khan et al. Leung's encyclopedia of common natural ingredients: used in food, drugs and cosmetics
Djordjevic From medicinal plant raw material to herbal remedies
CN103519043B (en) A kind of nutritive health-care honey and preparation method thereof
CN103815076A (en) Anoectochilus roxburghii health maintenance white tea and preparation method thereof
CN102688431A (en) Kidney-reinforcing oral liquid and preparation method thereof
CN103571613A (en) Preparation method of vitex negundo linn volatile oil
CN103285227A (en) Hypoglycemic Chinese medicine composition, hypoglycemic tea and preparation method of hypoglycemic tea
Palanisamy et al. Anti-ovarian cancer potential of phytocompound and extract from South African medicinal plants and their role in the development of chemotherapeutic agents
CN103800231A (en) Skin care wet wipe
CN103504437B (en) Forsythia leaf beverage
CN110339304A (en) A kind of antidepression composite essential oil containing CBD ingredient
CN101862412A (en) Chinese olive blood-sugar reducing tea
CN106038398A (en) Method for preparing cortex phellodendri extract and application of cortex phellodendri extract composition prepared from cortex phellodendri extract in bacteriostatic agent
CN102078374A (en) Tibetan medical dracocephalum heterophyllum benth extract and application thereof
CN104109616A (en) Lifetime-extension health-care medicinal liquor
CN104306492A (en) Drug with anti-bacterial and synergistically anti-bacterial activity, and preparation method and application thereof
CN106305712A (en) Fungicidal fertilizer granule containing Scutellaria baicalensis
CN114010737A (en) Anti-coronavirus composition, preparation method and application thereof
CN105267580A (en) Application of dianella ensifolia or extracts thereof
Paşayeva et al. Chemical composition, in vitro antioxidant, and antidiabetic potential of essential oil from flowers of Rhaponticoides iconiensis
CN102552641B (en) Chinese herbal medicine formula for preventing and treating broiler colibacillosis
CN105687820A (en) Health product capable of reducing blood fat
CN105853472B (en) A kind of red shellfish essential oil and preparation method
CN106176338B (en) A kind of anti-aging cosmetics composition and preparation method thereof
CN106188083B (en) A method of extracting 1, 8-Cineole volatile oil from folium artemisiae argyi

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20191018

RJ01 Rejection of invention patent application after publication